Condition: Lung Transplant Rejection · Sponsor: University of Alberta
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
This description comes directly from the study's public registry record.
Konrad S Famulski, PhD · 1 780 492 1725 · konrad@ualberta.ca
Robert Polakowski, PhD · 1 780 492 5091 · polakows@ualberta.ca
Always discuss trial participation with your own doctor first.
| St. Joseph's Hospital and Medical Center 350 West Thomas Road, Floor 8HLT | Phoenix, Arizona, United States | Recruiting |
| University of Maryland School of Medicine | Baltimore, Maryland, United States | Completed |
| Division of Pulmonary and Critical Care, Washington University School of Medicine | St Louis, Missouri, United States | Completed |
| University of Texas at San Antonio | San Antonio, Texas, United States | Completed |
| The Alfred Hospital, Monash University | Melbourne, Australia | Completed |
| Department of Thoracic Surgery, Medical University of Vienna | Vienna, Austria | Completed |
| Alberta Transplant Applied Genomics Centre, University of Alberta | Edmonton, Alberta, Canada | Recruiting |
| Department of Medicine, University of Alberta | Edmonton, Alberta, Canada | Recruiting |
| University Health Network, Toronto General Hospital | Toronto, Ontario, Canada | Completed |
| Charles University/Hospital Motol | Prague, Czechia | Recruiting |
| Thoracic Surgery Transplant Clinic | Szczecin, Poland | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02812290